Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Baxter touts data on Theranova Dialyser efficacy, toxin clearance
Baxter today presented data from 24 different abstracts on treatments for end-stage kidney disease, touting 8 that covered its Theranova dialyser, indicated for treating chronic and acute renal failure.
The study data was presented at the European Renal Association and European Dialysis and Transplant Association’s 53rd Congress this week. Read more
4. Insulet launches ‘Podder’ platform for Omnipod patients
Insulet said today that it launched a new online platform for diabetes patients who use its Omnipod insulin management system, alongside a new mobile app and new branding for the device.
“We have an incredibly engaged and active Podder community and are thrilled to now contribute and be part of the conversation on social media,” president Shacey Petrovic said in prepared remarks. “Each element of our new brand and visual identity highlights our dedication to serving our community of energized users, families, clinicians and partners through innovation and a commitment to reducing the burden of diabetes and improving health outcomes. Our new community platform is one of many steps we are taking to ensure we provide unparalleled support to our remarkable community of Podders.” Read more
3. Toyota resurrects DEKA’s iBot wheelchair
Toyota Motor North America said last week that it’s planning to resurrect the iBot stair-climbing wheelchair developed by famed investor Dean Kamen’s DEKA Research & Development company.
The deal calls for DEKA to complete the development and launch of a new version of the iBot, the Japanese auto maker said. Toyota said it will also license the balancing technology developed by the R&D firm for medical rehabilitation and perhaps other purposes. Read more
2. Luminex raises Nanosphere offer to $102m
Luminex said today that a 3rd-party offer for Nanosphere prompted it to raise its own $83 million bid for the company and its Verigene molecular diagnostics technology.
Last week Luminex offered $1.35 pe share for Nanosphere and said it would also pay off some $25 million of Nanosphere’s debt. Today the company said a $1.50-per-share bid from an unnamed 3rd party moved it to up the ante on its own offer to $1.70 per share, taking the total deal value to $102 million. Read more
1. NuVasive launches Attrax bone putty in the U.S.
NuVasive Inc. said today that it’s launching its Attrax bone putty in the U.S., after winning 510(k) clearance from the FDA in October 2015.
The synthetic bone graft putty is designed to encourage bone growth at the site of a spinal fusion procedure. Read more
The post MassDevice.com +5 | The top 5 medtech stories for May 23, 2016 appeared first on MassDevice.
from MassDevice http://ift.tt/1qFj1J0
Cap comentari:
Publica un comentari a l'entrada